Peripheral Drug Eluting Balloon Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global market for peripheral drug eluting balloons (DEBs) has experienced notable growth over recent years. DEBs are advanced medical devices used primarily in interventional cardiology and related fields to treat cardiovascular conditions, especially arterial blockages or stenosis. These devices combine the mechanical action of balloon angioplasty with localized medication delivery, effectively addressing lesions in blood vessels.The global peripheral drug-eluting balloon (DEB) market, valued at $942.75 million, is set to reach $1,687.3 million with an 8.70% CAGR, driven by their efficacy in treating arterial blockages and stenosis.

Market Dynamics:

Dominance of Paclitaxel Drug Coating: Paclitaxel-coated DEBs have emerged as a dominant force within the market, holding a significant share due to their efficacy in treating vascular conditions.
Revenue Contribution: Peripheral drug eluting balloons have significantly contributed to the overall revenue of the peripheral vascular devices market, highlighting their importance in the treatment Analysis.

Increasing Incidence of Peripheral Arterial Disease:

Peripheral vascular disease (PVD) involves the narrowing or obstruction of arteries leading to the limbs, often caused by the accumulation of fatty plaques. This condition is becoming more prevalent globally, largely due to lifestyle factors such as smoking, pollution, and other health issues. The rising incidence of PVD is a major factor driving the expansion of the DEB market.

Impact of Lifestyle Changes: The prevalence of peripheral arterial disease (PAD) has increased due to changes in lifestyle, including smoking and environmental pollution. These factors have significantly contributed to the health challenges faced by individuals, particularly older adults, necessitating effective treatment options like DEBs.

Factors Driving Increased Usage of Peripheral Drug Eluting Balloons:

1. Aging Population and Rising Vascular Disease Rates:

Geriatric Risk: As the population ages, the susceptibility to vascular diseases increases, leading to a growing demand for peripheral vascular surgeries. The need for stents and other interventions among the elderly has created substantial opportunities for DEB manufacturers.
Demographic Trends: Countries experiencing rapid growth in their elderly populations are seeing increased demand for vascular treatments. The trend towards an older demographic underscores the need for advanced medical devices like DEBs to address the rising incidence of vascular conditions. This shift in demographics highlights the growing market for DEBs and the necessity for innovations in vascular health management.
Market Implications: The expansion of the elderly population in various regions has important implications for the DEB market. As the number of older individuals increases, so does the demand for effective treatments for peripheral arterial disease, driving growth in the DEB sector.

Challenges Facing Market Players:

1. High Product Cost and Limited Clinical Evidence:

Cost Constraints: One of the significant challenges for the adoption of peripheral DEBs is their relatively high cost compared to traditional treatments such as angioplasty or stenting. The expenses associated with DEBs, including the device and drug components, can be a barrier to widespread use, especially in regions with constrained healthcare budgets or reimbursement challenges.
Clinical Evidence Requirements: Despite promising results in clinical trials, there remains a need for extensive and long-term clinical evidence to demonstrate the efficacy and advantages of DEBs over alternative treatments. The availability of large-scale, long-term data is crucial for healthcare providers to gain confidence in adopting DEBs as a standard treatment option. The lack of comprehensive clinical evidence can impact market growth and hinder the broader acceptance of DEBs.

Regional Insights:

United States Market:
- The U.S. represents a substantial portion of the global peripheral drug eluting balloons market. The high prevalence of peripheral arterial disease in the country significantly contributes to its prominent position in the market. The demand for advanced vascular treatments in the U.S. is driven by the high incidence of PAD and an aging population.

Competitive Analysis

Key Companies Covered

Abbott Laboratories
Boston Scientific Corporation
Cook Medical Inc.
MicroPort Scientific Corporation (Endovastec(TM))
Medtronic Plc.
Cardinal Health, Inc.
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
W. L. Gore & Associates Inc.
Getinge AB
Terumo Corp
Kyoto Medical Planning Co Ltd
iVascular S.L.U
AMG International GmbH
ENDOCOR GmbH
Meril Life Sciences Pvt. Ltd.
Nano Therapeutics Pvt Ltd
Koninklijke Philips N.V.
REVA Medical

Key Segments of Peripheral Drug Eluting Balloons Industry Research

Drug Coating:

Paclitaxel Drug Coating
Sirolimus drug Coating
Others

Indication:

Peripheral Arterial Disease
Peripheral Aneurysms
In-Stent Restenosis
Others

Artery Type:

Carotid Arteries
Fem-Pop Arteries
Iliac Arteries
Infrapop Arteries

End User:

Hospitals
Ambulatory Surgical Centers/Outpatients
Cardiac Catheterization Labs

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

1. Executive Summary

1.1. Global Peripheral Drug Eluting Balloon Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Volume and Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. Covid-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact Of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. Pestle Analysis

3. Production Output and Trade Statistics, 2019-2023

3.1. Global Peripheral Drug Eluting Balloon Market Production Output, by Region, Value (US$ Mn) and Volume (Million Units),2019-2023
- 3.1.1. North America
- 3.1.2. Europe
- 3.1.3. Asia Pacific
- 3.1.4. Latin America
- 3.1.5. Middle East and Africa

4. Price Analysis, 2019-2023

4.1. Global Average Price Analysis, by Drug Coating/ Material, US$ Per Unit, 2019-2023
4.2. Prominent Factor Affecting Peripheral Drug Eluting Balloon Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit, 2019-2023

5. Global Peripheral Drug Eluting Balloon Market Outlook, 2019-2031

5.1. Global Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Paclitaxel Drug Coating
  - 5.1.1.2. Sirolimus drug Coating
  - 5.1.1.3. Others
5.2. Global Peripheral Drug Eluting Balloon Market Outlook, by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Peripheral Arterial Disease
  - 5.2.1.2. Peripheral Aneurysms
  - 5.2.1.3. In-Stent Restenosis
  - 5.2.1.4. Others
5.3. Global Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Carotid Arteries
  - 5.3.1.2. Fem-Pop Arteries
  - 5.3.1.3. Iliac Arteries
  - 5.3.1.4. Infrapop Arteries
5.4. Global Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Hospitals
  - 5.4.1.2. Ambulatory Surgical Centers/Outpatients
  - 5.4.1.3. Cardiac Catheterization Labs
5.5. Global Peripheral Drug Eluting Balloon Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 5.5.1. Key Highlights
  - 5.5.1.1. North America
  - 5.5.1.2. Europe
  - 5.5.1.3. Asia Pacific
  - 5.5.1.4. Latin America
  - 5.5.1.5. Middle East & Africa

6. North America Peripheral Drug Eluting Balloon Market Outlook, 2019-2031

6.1. North America Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Peripheral Arterial Disease
  - 6.1.1.2. Peripheral Aneurysms
  - 6.1.1.3. In-Stent Restenosis
  - 6.1.1.4. Others
6.2. North America Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Carotid Arteries
  - 6.2.1.2. Fem-Pop Arteries
  - 6.2.1.3. Iliac Arteries
  - 6.2.1.4. Infrapop Arteries
6.3. North America Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals
  - 6.3.1.2. Ambulatory Surgical Centers/Outpatients
  - 6.3.1.3. Cardiac Catheterization Labs
6.4. North America Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Hospitals
  - 6.4.1.2. Cosmetic & Plastic Surgery Clinics
  - 6.4.1.3. Ambulatory Surgical Centres
6.5. North America Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 6.5.1. Key Highlights
  - 6.5.1.1. U.S. Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 6.5.1.2. U.S. Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 6.5.1.3. U.S. Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 6.5.1.4. U.S. Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 6.5.1.5. Canada Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 6.5.1.6. Canada Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 6.5.1.7. Canada Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 6.5.1.8. Canada Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Europe Peripheral Drug Eluting Balloon Market Outlook, 2019-2031

7.1. Europe Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Peripheral Arterial Disease
  - 7.1.1.2. Peripheral Aneurysms
  - 7.1.1.3. In-Stent Restenosis
  - 7.1.1.4. Others
7.2. Europe Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Carotid Arteries
  - 7.2.1.2. Fem-Pop Arteries
  - 7.2.1.3. Iliac Arteries
  - 7.2.1.4. Infrapop Arteries
7.3. Europe Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals
  - 7.3.1.2. Ambulatory Surgical Centers/Outpatients
  - 7.3.1.3. Cardiac Catheterization Labs
7.4. Europe Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Hospitals
  - 7.4.1.2. Cosmetic & Plastic Surgery Clinics
  - 7.4.1.3. Ambulatory Surgical Centres
7.5. Europe Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Germany Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.2. Germany Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.3. Germany Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.4. Germany Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.5. U.K. Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.6. U.K. Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.7. U.K. Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.8. U.K. Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.9. France Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.10. France Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.11. France Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.12. France Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.13. Italy Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.14. Italy Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.15. Italy Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.16. Italy Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.17. Turkey Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.18. Turkey Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.19. Turkey Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.20. Turkey Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.21. Russia Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.22. Russia Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.23. Russia Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.24. Russia Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.25. Rest Of Europe Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.26. Rest Of Europe Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.27. Rest Of Europe Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 7.5.1.28. Rest of Europe Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, 2019-2031

8.1. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Peripheral Arterial Disease
  - 8.1.1.2. Peripheral Aneurysms
  - 8.1.1.3. In-Stent Restenosis
  - 8.1.1.4. Others
8.2. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Carotid Arteries
  - 8.2.1.2. Fem-Pop Arteries
  - 8.2.1.3. Iliac Arteries
  - 8.2.1.4. Infrapop Arteries
8.3. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals
  - 8.3.1.2. Ambulatory Surgical Centers/Outpatients
  - 8.3.1.3. Cardiac Catheterization Labs
8.4. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Hospitals
  - 8.4.1.2. Cosmetic & Plastic Surgery Clinics
  - 8.4.1.3. Ambulatory Surgical Centres
8.5. Asia Pacific Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 8.5.1. Key Highlights
  - 8.5.1.1. China Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.2. China Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.3. China Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.4. China Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.5. Japan Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.6. Japan Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.7. Japan Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.8. Japan Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.9. South Korea Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.10. South Korea Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.11. South Korea Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.12. South Korea Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.13. India Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.14. India Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.15. India Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.16. India Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.17. Southeast Asia Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.18. Southeast Asia Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.19. Southeast Asia Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.20. Southeast Asia Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.21. Rest Of Asia Pacific Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.22. Rest Of Asia Pacific Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.23. Rest Of Asia Pacific Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 8.5.1.24. Rest of Asia Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Latin America Peripheral Drug Eluting Balloon Market Outlook, 2019-2031

9.1. Latin America Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 9.1.1. Key Highlights
  - 9.1.1.1. Peripheral Arterial Disease
  - 9.1.1.2. Peripheral Aneurysms
  - 9.1.1.3. In-Stent Restenosis
  - 9.1.1.4. Others
9.2. Latin America Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 9.2.1. Key Highlights
  - 9.2.1.1. Carotid Arteries
  - 9.2.1.2. Fem-Pop Arteries
  - 9.2.1.3. Iliac Arteries
  - 9.2.1.4. Infrapop Arteries
9.3. Latin America Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 9.3.1. Key Highlights
  - 9.3.1.1. Hospitals
  - 9.3.1.2. Ambulatory Surgical Centers/Outpatients
  - 9.3.1.3. Cardiac Catheterization Labs
9.4. Latin America Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 9.4.1. Key Highlights
  - 9.4.1.1. Hospitals
  - 9.4.1.2. Cosmetic & Plastic Surgery Clinics
  - 9.4.1.3. Ambulatory Surgical Centres
9.5. Latin America Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 9.5.1. Key Highlights
  - 9.5.1.1. Brazil Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.2. Brazil Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.3. Brazil Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.4. Brazil Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.5. Mexico Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.6. Mexico Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.7. Mexico Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.8. Mexico Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.9. Argentina Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.10. Argentina Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.11. Argentina Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.12. Argentina Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.13. Rest Of Latin America Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.14. Rest Of Latin America Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.15. Rest Of Latin America Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 9.5.1.16. Rest of Latin America Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 9.5.2. BPS Analysis/Market Attractiveness Analysis

10. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, 2019-2031

10.1. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 10.1.1. Key Highlights
  - 10.1.1.1. Peripheral Arterial Disease
  - 10.1.1.2. Peripheral Aneurysms
  - 10.1.1.3. In-Stent Restenosis
  - 10.1.1.4. Others
10.2. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 10.2.1. Key Highlights
  - 10.2.1.1. Carotid Arteries
  - 10.2.1.2. Fem-Pop Arteries
  - 10.2.1.3. Iliac Arteries
  - 10.2.1.4. Infrapop Arteries
10.3. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 10.3.1. Key Highlights
  - 10.3.1.1. Hospitals
  - 10.3.1.2. Ambulatory Surgical Centers/Outpatients
  - 10.3.1.3. Cardiac Catheterization Labs
10.4. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 10.4.1. Key Highlights
  - 10.4.1.1. Hospitals
  - 10.4.1.2. Cosmetic & Plastic Surgery Clinics
  - 10.4.1.3. Ambulatory Surgical Centres
10.5. Middle East & Africa Peripheral Drug Eluting Balloon Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 10.5.1. Key Highlights
  - 10.5.1.1. GCC Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.2. GCC Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.3. GCC Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.4. GCC Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.5. South Africa Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.6. South Africa Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.7. South Africa Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.8. South Africa Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.9. Egypt Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.10. Egypt Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.11. Egypt Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.12. Egypt Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.13. Nigeria Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.14. Nigeria Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.15. Nigeria Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.16. Nigeria Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.17. Rest Of Middle East & Africa Peripheral Drug Eluting Balloon Market by Drug Coating, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.18. Rest Of Middle East & Africa Peripheral Drug Eluting Balloon Market by Indication, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.19. Rest Of Middle East & Africa Peripheral Drug Eluting Balloon Market by Artery Type, Value (US$ Mn) and Volume (Million Units), 2019-2031
  - 10.5.1.20. Rest of Middle East & Africa Peripheral Drug Eluting Balloon Market by End User, Value (US$ Mn) and Volume (Million Units), 2019-2031
- 10.5.2. BPS Analysis/Market Attractiveness Analysis

11. Competitive Landscape

11.1. By Artery Type Vs by Indication Heat Map
11.2. Manufacturer Vs by Indication Heatmap
11.3. Company Market Share Analysis, 2023
11.4. Competitive Dashboard
11.5. Company Profiles
- 11.5.1. Abbott Laboratories
  - 11.5.1.1. Company Overview
  - 11.5.1.2. Drug Coating Portfolio
  - 11.5.1.3. Financial Overview
  - 11.5.1.4. Business Strategies and Development
- 11.5.2. Boston Scientific Corporation
  - 11.5.2.1. Company Overview
  - 11.5.2.2. Drug Coating Portfolio
  - 11.5.2.3. Financial Overview
  - 11.5.2.4. Business Strategies and Development
- 11.5.3. Cook Medical Inc.
  - 11.5.3.1. Company Overview
  - 11.5.3.2. Drug Coating Portfolio
  - 11.5.3.3. Financial Overview
  - 11.5.3.4. Business Strategies and Development
- 11.5.4. MicroPort Scientific Corporation (Endovastec(TM))
  - 11.5.4.1. Company Overview
  - 11.5.4.2. Drug Coating Portfolio
  - 11.5.4.3. Financial Overview
  - 11.5.4.4. Business Strategies and Development
- 11.5.5. Medtronic Plc.
  - 11.5.5.1. Company Overview
  - 11.5.5.2. Drug Coating Portfolio
  - 11.5.5.3. Financial Overview
  - 11.5.5.4. Business Strategies and Development
- 11.5.6. Cardinal Health, Inc.
  - 11.5.6.1. Company Overview
  - 11.5.6.2. Drug Coating Portfolio
  - 11.5.6.3. Financial Overview
  - 11.5.6.4. Business Strategies and Development
- 11.5.7. B. Braun Melsungen AG
  - 11.5.7.1. Company Overview
  - 11.5.7.2. Drug Coating Portfolio
  - 11.5.7.3. Financial Overview
  - 11.5.7.4. Business Strategies and Development
- 11.5.8. BIOTRONIK SE & Co. KG
  - 11.5.8.1. Company Overview
  - 11.5.8.2. Drug Coating Portfolio
  - 11.5.8.3. Financial Overview
  - 11.5.8.4. Business Strategies and Development
- 11.5.9. Becton, Dickinson and Company
  - 11.5.9.1. Company Overview
  - 11.5.9.2. Drug Coating Portfolio
  - 11.5.9.3. Financial Overview
  - 11.5.9.4. Business Strategies and Development
- 11.5.10. W. L. Gore & Associates Inc.
  - 11.5.10.1. Company Overview
  - 11.5.10.2. Drug Coating Portfolio
  - 11.5.10.3. Financial Overview
  - 11.5.10.4. Business Strategies and Development
- 11.5.11. Getinge AB
  - 11.5.11.1. Company Overview
  - 11.5.11.2. Drug Coating Portfolio
  - 11.5.11.3. Financial Overview
  - 11.5.11.4. Business Strategies and Development
- 11.5.12. Terumo Corp
  - 11.5.12.1. Company Overview
  - 11.5.12.2. Drug Coating Portfolio
  - 11.5.12.3. Financial Overview
  - 11.5.12.4. Business Strategies and Development
- 11.5.13. Kyoto Medical Planning Co Ltd
  - 11.5.13.1. Company Overview
  - 11.5.13.2. Drug Coating Portfolio
  - 11.5.13.3. Financial Overview
  - 11.5.13.4. Business Strategies and Development
- 11.5.14. iVascular S.L.U
  - 11.5.14.1. Company Overview
  - 11.5.14.2. Drug Coating Portfolio
  - 11.5.14.3. Financial Overview
  - 11.5.14.4. Business Strategies and Development
- 11.5.15. AMG International GmbH
  - 11.5.15.1. Company Overview
  - 11.5.15.2. Drug Coating Portfolio
  - 11.5.15.3. Financial Overview
  - 11.5.15.4. Business Strategies and Development
- 11.5.16. ENDOCOR GmbH
  - 11.5.16.1. Company Overview
  - 11.5.16.2. Drug Coating Portfolio
  - 11.5.16.3. Financial Overview
  - 11.5.16.4. Business Strategies and Development
- 11.5.17. Meril Life Sciences Pvt. Ltd.
  - 11.5.17.1. Company Overview
  - 11.5.17.2. Drug Coating Portfolio
  - 11.5.17.3. Financial Overview
  - 11.5.17.4. Business Strategies and Development
- 11.5.18. Nano Therapeutics Pvt Ltd
  - 11.5.18.1. Company Overview
  - 11.5.18.2. Drug Coating Portfolio
  - 11.5.18.3. Financial Overview
  - 11.5.18.4. Business Strategies and Development
- 11.5.19. Koninklijke Philips N.V.
  - 11.5.19.1. Company Overview
  - 11.5.19.2. Drug Coating Portfolio
  - 11.5.19.3. Financial Overview
  - 11.5.19.4. Business Strategies and Development
- 11.5.20. REVA Medical
  - 11.5.20.1. Company Overview
  - 11.5.20.2. Drug Coating Portfolio
  - 11.5.20.3. Financial Overview
  - 11.5.20.4. Business Strategies and Development

12. Appendix

12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms And Abbreviations